132 related articles for article (PubMed ID: 9586768)
1. F344/Shi rats bearing type b catalase-1 locus are sensitive to sodium L-ascorbate promotion of two-stage urinary bladder carcinogenesis.
Mori S; Murai T; Hosono M; Yamashita H; Oohara T; Makino S; Doteuchi M; Fukushima S
Teratog Carcinog Mutagen; 1998; 18(1):27-33. PubMed ID: 9586768
[TBL] [Abstract][Full Text] [Related]
2. Lack of promotion of urinary bladder carcinogenesis by sodium bicarbonate and/or L-ascorbic acid in male ODS/Shi-od/od rats synthesizing alpha 2 mu-globulin but not L-ascorbic acid.
Mori S; Murai T; Hosono M; Machino S; Makino S; Chou C; Fukushima S
Food Chem Toxicol; 1997 Aug; 35(8):783-7. PubMed ID: 9350223
[TBL] [Abstract][Full Text] [Related]
3. No promotion of urinary bladder carcinogenesis by sodium L-ascorbate in male ODS/Shi-od/od rats lacking L-ascorbic acid-synthesizing ability.
Mori S; Murai T; Takeuchi Y; Hosono M; Ohhara T; Makino S; Hayashi Y; Shibata MA; Kurata Y; Hagiwara A
Carcinogenesis; 1991 Oct; 12(10):1869-73. PubMed ID: 1934267
[TBL] [Abstract][Full Text] [Related]
4. Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
Chen TX; Wanibuchi H; Murai T; Kitano M; Yamamoto S; Fukushima S
Jpn J Cancer Res; 1999 Jan; 90(1):16-22. PubMed ID: 10076560
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
[TBL] [Abstract][Full Text] [Related]
6. Quantitative trait loci associated with promoting effects of sodium L-ascorbate on two-stage bladder carcinogenesis in rats.
Kamoto T; Mori S; Murai T; Yamada Y; Makino S; Yoshida O; Hiai H
Jpn J Cancer Res; 1997 Jul; 88(7):633-8. PubMed ID: 9310135
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
[TBL] [Abstract][Full Text] [Related]
8. Strain differences in sensitivity to the promoting effect of sodium L-ascorbate in a two-stage rat urinary bladder carcinogenesis model.
Murai T; Mori S; Hosono M; Takashima A; Machino S; Oohara T; Yamashita H; Makino S; Matsuda T; Wanibuchi H; Fukushima S
Jpn J Cancer Res; 1997 Mar; 88(3):245-53. PubMed ID: 9140108
[TBL] [Abstract][Full Text] [Related]
9. Concentration dependent promoting effects of sodium L-ascorbate with the same total dose in a rat two-stage urinary bladder carcinogenesis.
Chen TX; Wanibuchi H; Wei M; Morimura K; Yamamoto S; Hayashi S; Fukushima S
Cancer Lett; 1999 Nov; 146(1):67-71. PubMed ID: 10656611
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
11. Synergism by sodium L-ascorbate but inhibition by L-ascorbic acid for sodium saccharin promotion of rat two-stage bladder carcinogenesis.
Fukushima S; Uwagawa S; Shirai T; Hasegawa R; Ogawa K
Cancer Res; 1990 Jul; 50(14):4195-8. PubMed ID: 2364375
[TBL] [Abstract][Full Text] [Related]
12. Lack of promotion of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in mice by rat cancer promoters.
Tamano S; Asakawa E; Boomyaphiphat P; Masui T; Fukushima S
Teratog Carcinog Mutagen; 1993; 13(2):89-96. PubMed ID: 8102212
[TBL] [Abstract][Full Text] [Related]
13. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
[TBL] [Abstract][Full Text] [Related]
14. Significant overexpression of metallothionein and cyclin D1 and apoptosis in the early process of rat urinary bladder carcinogenesis induced by treatment with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium L-ascorbate.
Takaba K; Saeki K; Suzuki K; Wanibuchi H; Fukushima S
Carcinogenesis; 2000 Apr; 21(4):691-700. PubMed ID: 10753205
[TBL] [Abstract][Full Text] [Related]
15. L-ascorbic acid amplification of bladder carcinogenesis promotion by K2CO3.
Fukushima S; Kurata Y; Hasegawa R; Asamoto M; Shibata MA; Tamano S
Cancer Res; 1991 May; 51(10):2548-51. PubMed ID: 2021935
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent amplification by L-ascorbic acid of NaHCO3 promotion of rat urinary bladder carcinogenesis.
Iwata H; Yamamoto S; Yano Y; Ohtani S; Fukushima S
Toxicol Pathol; 1997; 25(3):284-90. PubMed ID: 9210260
[TBL] [Abstract][Full Text] [Related]
17. Severity of promotion by sodium salts of succinic acid in rat urinary bladder carcinogenesis correlates with sodium ion concentration under conditions of equal urinary pH.
Otoshi T; Iwata H; Yamamoto S; Murai T; Yamaguchi S; Matsui-Yuasa I; Otani S; Fukushima S
Carcinogenesis; 1993 Nov; 14(11):2277-81. PubMed ID: 8242855
[TBL] [Abstract][Full Text] [Related]
18. Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats.
Fukushima S; Imaida K; Sakata T; Okamura T; Shibata M; Ito N
Cancer Res; 1983 Sep; 43(9):4454-7. PubMed ID: 6871876
[TBL] [Abstract][Full Text] [Related]
19. Promoting effect of sodium o-phenylphenate and o-phenylphenol on two-stage urinary bladder carcinogenesis in rats.
Fukushima S; Kurata Y; Shibata M; Ikawa E; Ito N
Gan; 1983 Oct; 74(5):625-32. PubMed ID: 6642136
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
